Literature DB >> 9452486

Transcriptional repression by v-Ski and c-Ski mediated by a specific DNA binding site.

R Nicol1, E Stavnezer.   

Abstract

The Ski oncoprotein has been shown to bind DNA and activate transcription in conjunction with other cellular factors. Because tumor cells or myogenic cells were used for those studies, it is not clear that those activities of Ski are related to its transforming ability. In this study, we use a nuclear extract of c-ski-transformed cells to identify a specific DNA binding site for Ski with the consensus sequence GTCTAGAC. We demonstrate that both c-Ski and v-Ski in nuclear extracts are components of complexes that bind specifically to this site. By evaluating the features of the sequence that are critical for binding, we show that binding is cooperative. Although Ski cannot bind to this sequence on its own, we use cross-linking with ultraviolet light to show that Ski binds to this site along with several unidentified cellular proteins. Furthermore, we find that Ski represses transcription either through upstream copies of this element or when brought to the promoter by a heterologous DNA binding domain. This is the first demonstration that Ski acts as a repressor rather than an activator and could provide new insights into regulation of gene expression by Ski.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452486     DOI: 10.1074/jbc.273.6.3588

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Ski interacts with the evolutionarily conserved SNW domain of Skip.

Authors:  T Prathapam; C Kühne; M Hayman; L Banks
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

2.  The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease.

Authors:  Sofie Singbrant; Meaghan Wall; Jennifer Moody; Göran Karlsson; Alistair M Chalk; Brian Liddicoat; Megan R Russell; Carl R Walkley; Stefan Karlsson
Journal:  Haematologica       Date:  2014-01-10       Impact factor: 9.941

Review 3.  Transcriptional Control by the SMADs.

Authors:  Caroline S Hill
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

4.  Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling.

Authors:  R Dahl; M Kieslinger; H Beug; M J Hayman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

5.  Characterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoter.

Authors:  S M Ogbourne; T M Antalis
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

6.  The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice.

Authors:  T Shinagawa; H D Dong; M Xu; T Maekawa; S Ishii
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

7.  Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.

Authors:  W Xu; K Angelis; D Danielpour; M M Haddad; O Bischof; J Campisi; E Stavnezer; E E Medrano
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

8.  The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling.

Authors:  K Luo; S L Stroschein; W Wang; D Chen; E Martens; S Zhou; Q Zhou
Journal:  Genes Dev       Date:  1999-09-01       Impact factor: 11.361

9.  Defective T-cell activation is associated with augmented transforming growth factor Beta sensitivity in mice with mutations in the Sno gene.

Authors:  S Pearson-White; M McDuffie
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

10.  Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-β signaling.

Authors:  Shaun Tulley; Wen-Tien Chen
Journal:  J Biol Chem       Date:  2014-04-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.